The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation: Two Systematic Literature Reviews and Meta-Analyses
Abstract
BACKGROUND: Although radiofrequency catheter ablation (RFA) has evolved from an experimental procedure to an important treatment option for atrial fibrillation, the relative safety and efficacy of catheter ablation relative to that of antiarrhythmic drug (AAD) therapy has not been established. METHODS AND RESULTS: Two separate systematic reviews were conducted: one on RFA and the other on AAD to provide accurate and broadly representative estimates of the clinical efficacy and safety of both therapies in the treatment of atrial fibrillation. Electronic searches were conducted in EMBASE and MEDLINE from 1990 to 2007. For the RFA review, all study designs were accepted. For the AAD review, articles were limited to prospective studies on the following drugs of interest: amiodarone, dofetilide, sotalol, flecainide, and propafenone. Data were extracted by 1 reviewer, with a second reviewer performing independent confirmation of extracted data. Sixty-three RFA and 34 AAD studies were included in the reviews. Patients enrolled in RFA studies tended to be younger (mean age, 55 versus 62 years), had longer duration of atrial fibrillation (6.0 versus 3.1 years), and had failed a greater number of prior drug trials (2.6 versus 1.7). The single-procedure success rate of ablation off AAD therapy was 57% (95% CI, 50% to 64%), the multiple procedure success rate off AAD was 71% (95% CI, 65% to 77%), and the multiple procedure success rate on AAD or with unknown AAD usage was 77% (95% CI, 73% to 81%). In comparison, the success rate for AAD therapy was 52% (95% CI, 47% to 57%). A major complication of catheter ablation occurred in 4.9% of patients. Adverse events for AAD studies, although more common (30% versus 5%), were less severe. CONCLUSIONS: Studies of RFA for treatment of atrial fibrillation report higher efficacy rates than do studies of AAD therapy and a lower rate of complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Catheter ablation of AF is effective in restoring and maintaining sinus rhythm in patients with symptomatic paroxysmal, persistent, and probably long-standing persistent AF -in general as second-line treatment after failure of or intolerance to antiarrhythmic drug therapy.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“In such patients, catheter ablation is more effective than antiarrhythmic drug therapy.185,586,713,[717][718][719][720]”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“In patients who experience symptomatic recurrences of AF despite antiarrhythmic drug therapy, all RCTs showed better sinus rhythm maintenance with catheter ablation than on antiarrhythmic drugs.586,713,727,728”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“Most patients require more than one procedure to achieve symptom control.713,726,728”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“The rhythm outcome after catheter ablation of AF is difficult to predict in individual patients.173,227,713,728”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“Sinus rhythm without severely symptomatic recurrences of AF is found in up to 70% of patients with paroxysmal AF, and around 50% in persistent AF. 713,728,735,1042”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
In the citing paper
“a meta-analysis of the available (weak) evidence suggests slightly better prevention of recurrent AF in patients treated with antiarrhythmic drugs after catheter ablation.713”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [713]
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Cappato, R., Calkins, H., Chen, S.-A., Davies, W., Iesaka, Y., Kalman, J., Kim, Y.-H., Klein, G., Natale, A., Packer, D., et al. (2010) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.859116 · Cited by 2,852
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions
Cook, D. J., Mulrow, C. D., & Haynes, R. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-5-199703010-00006 · Cited by 2,184
Nademanee, K., McKenzie, J. P., Kosar, E. M., Schwab, M., Sunsaneewitayakul, B., Vasavakul, T., Khunnawat, C., & Ngarmukos, T. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.054 · Cited by 2,004
Calkins, H. G., Brugada, J., Packer, D. L., Cappato, R., Chen, S., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Haines, D. E., Haı̈ssaguerre, M., et al. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.04.005 · Cited by 1,690
Initiation of Atrial Fibrillation by Ectopic Beats Originating From the Pulmonary Veins
Chen, S., HSIEH, M., TAI, C., Tsai, C.-F., Prakash, V. S., Yu, W., Hsu, T., Ding, Y.-A., & Chang, M.-S. (1999) · Circulation · doi:10.1161/01.cir.100.18.1879 · Cited by 1,442
Cappato, R., Calkins, H. G., Chen, S., Davies, W. D., Iesaka, Y., Kalman, J. M., Kim, Y.-H., Klein, G. J., Packer, D. L., & Skanes, A. C. (2005) · Circulation · doi:10.1161/01.cir.0000157153.30978.67 · Cited by 1,303
Calkins, H. G., Brugada, J., Packer, D. L., Cappato, R., Chen, S.-A., Crijns, H. J. G. M., Damiano, R. J., Davies, D. W., Haines, D. E., Haïssaguerre, M., et al. (2007) · EP Europace · doi:10.1093/europace/eum120 · Cited by 1,289
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.009 · Cited by 1,161
Amiodarone to Prevent Recurrence of Atrial Fibrillation
Roy, D., Talajic, M. R., Dorian, P., Connolly, S. J., Eisenberg, M. J., Green, M. S., Kuś, T., Lambert, J., Dubuc, M., Gagné, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421302 · Cited by 1,142
Research works printed but not linked: 1
- 10.1161/circ.98.23.2574 · DOI
Cited by
Sorted by citations
Items 301–400 of 847
Catheter ablation of atrial fibrillation in the elderly: does the benefit outweigh the risk?
Kennedy, R. T., & Oral, H. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.13.2 · Cited by 19
Teuwen, C. P., Kik, C., van der Does, L. J. M. E., Lanters, E. A. H., Knops, P., Mouws, E. M. J. P., Bogers, A. J. J. C., & de Groot, N. M. S. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.005745 · Cited by 19
Sinus Rhythm Restoration and Treatment Success: Insight From Recent Clinical Trials
Saliba, W. I., & Wazni, O. M. (2011) · Clinical Cardiology · doi:10.1002/clc.20826 · Cited by 19
Greiß, H., Berkowitsch, A., Wójcik, M., Zaltsberg, S., Pajitnev, D., Deubner, N., Akkaya, E., Güttler, N., Hamm, C. W., Neumann, T., et al. (2015) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12637 · Cited by 19
“Exclusion criteria were defined as the following: (1) advanced structural heart disease, including moderate-tosevere valvular stenosis or insufficiency; (2) previous myocardial infarction; (3) congenital heart disease; (4) left ventricular ejection fraction <50%; (5) coronary artery bypass graft surgery within 3 month…”
BackgroundAblation as First-line Therapy for Atrial Fibrillation
Andrade, J. G. (2023) · European Cardiology Review · doi:10.15420/ecr.2023.04 · Cited by 20
Takahashi, A. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0693 · Cited by 18
Ablation of Multiwavelet Re-entry Guided by Circuit-Density and Distribution
Carrick, R. T., Benson, B. E., Habel, N., Bates, O. R. J., Bates, J. H. T., & Spector, P. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000759 · Cited by 18
“1229 Atrial fibrillation (AF), despite its prevalence and clinical and financial impact,(1) has remained difficult to treat either pharmacologically or interventionally.(2) Catheter ablation is potentially curative but has demonstrated only modest success in paroxysmal AF and yields relatively poor results when applie…”
BackgroundKeçe, F., Zeppenfeld, K., & Trines, S. A. I. P. (2018) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2018.7.3 · Cited by 18
Furui, K., Morishima, I., Morita, Y., Kanzaki, Y., Takagi, K., Yoshida, R., Nagai, H., Watanabe, N., Yoshioka, N., Yamauchi, R., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12303 · Cited by 17
Brown, S. M., Larsen, N. K., Thankam, F. G., & Agrawal, D. K. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03980-8 · Cited by 17
“For patients with persistent or refractory AF, radiofrequency catheter ablation has shown higher efficacy rates when compared to antiarrhythmic drugs [5].”
BackgroundZhang, J., Xia, S., Du, X., Jiang, C., Lai, Y., Wang, Y., Jia, Z., He, L., Tang, R., Dong, J., et al. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02139-7 · Cited by 19
LaBarbera, M. A., Atta-Fosu, T., Feeny, A. K., Firouznia, M., McHale, M. L., Cantlay, C., Roach, T., Axtell, A., Schoenhagen, P., Barnard, J., et al. (2021) · IEEE Journal of Translational Engineering in Health and Medicine · doi:10.1109/jtehm.2021.3134160 · Cited by 17
In-Hospital Management of Atrial Fibrillation: The CHADS2 Score Predicts Increased Cost
Kotowycz, M. A., Filion, K. B., Joza, J. E., Dube, D., Reynolds, M. R., Pilote, L., Eisenberg, M. J., & Essebag, V. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.01.002 · Cited by 17
Yalçın, M. U., Gürses, K. M., Koçyiğit, D., Kesikli, S. A., Dural, M., Evranos, B., Yorgun, H., ŞAHINER, L., Kaya, E. B., Oto, M. A., et al. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12665 · Cited by 17
Atrial Fibrillation in the Elderly: A Review
Hakim, F. A., & Shen, W.-K. (2014) · Future Cardiology · doi:10.2217/fca.14.32 · Cited by 19
Yano, M., Egami, Y., Ukita, K., Kawamura, A., Nakamura, H., Matsuhiro, Y., Yasumoto, K., Tsuda, M., Okamoto, N., Tanaka, A., et al. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100664 · Cited by 19
Hao, S. C., Hunter, T. D., Gunnarsson, C., March, J. L., White, S., Ladapo, J. A., & Reynolds, M. R. (2012) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-012-9690-5 · Cited by 16
Rosso, R., Chorin, E., Levi, Y., Rogowski, O., & Viskin, S. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13058 · Cited by 16
“This group included the following patient categories: (1) 19 patients who presented to the ablation procedure in sinus rhythm after undergoing DC shock while on amiodarone therapy 1 month prior to the procedure.”
BackgroundResultChen, X., Zhao, J., Zhu, K., Qin, F., Liu, H., & Tao, H. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.756552 · Cited by 16
Mehrnia, M., Kholmovski, E. G., Katsaggelos, A. K., Kim, D. J., PASSMAN, R. S., & Elbaz, M. S. M. (2024) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2024.3476930 · Cited by 18
Actualización detallada de las guías de la ESC para el manejo de la fibrilación auricular de 2012
Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., Baumgartner, H., et al. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.11.001 · Cited by 16
Looi, K., Gajendragadkar, P. R., Taha, T., Elsik, M., Scully, E., Heck, P. M., Fynn, S. P., Virdee, M., & Begley, D. (2012) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-012-9744-8 · Cited by 16
Gal, P., Ooms, J. F., Ottervanger, J. P., Smit, J. J. J., Adıyaman, A., Misier, A. R. R., Delnoy, P. P. H. M., Jager, P. L., & Elvan, A. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu321 · Cited by 16
Atrial Fibrillation and Deterioration in Cognitive Function
Chinta, V., Askandar, S., Nanda, A. S., Sharma, A., Abader, P., Kabra, R., & Khouzam, R. N. (2018) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2018.07.001 · Cited by 16
Cluckey, A., Perino, A. C., Yunus, F. N., Leef, G. C., Askari, M., Heidenreich, P. A., Narayan, S. M., Wang, P. J., & Turakhia, M. P. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009976 · Cited by 16
Al‐Khatib, S. M., Calkins, H. G., Eloff, B. C., Kowey, P. R., Hammill, S. C., Ellenbogen, K. A., Marinac‐Dabic, D., Waldo, A. L., Brindis, R. G., Wilbur, D. J., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.06.044 · Cited by 16
“the highly selected patients who were relatively young and who had no or mild structural heart disease, and the highly variable monitoring for recurrent AF during follow-up.(1-11) Some of these limitations will be addressed by the Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation Trial (CABA…”
BackgroundRadiation Exposure and Safety for the Electrophysiologist
Ernst, S., & Castellano, I. A. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0402-2 · Cited by 16
“Some procedures like catheter ablation of atrial fibrillation frequently requires more than one ablation procedure, thereby adding a substantial amount of radiation [6].”
History of transcatheter atrial fibrillation ablation
Anselmino, M., D’Ascenzo, F., Amoroso, G. R., Ferraris, F., & Gaïta, F. (2011) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32834ead59 · Cited by 16
Teuwen, C. P., Korevaar, T. I. M., Coolen, R. L., van der Wel, T., Houck, C. A., Evertz, R., Yaksh, A., Roos‐Hesselink, J. W., Bogers, A. J. J. C., & de Groot, N. M. S. (2016) · EP Europace · doi:10.1093/europace/euw300 · Cited by 16
“Mild dysfunction (%) 121 (24) 43 (17) 62 (28) 16 (42)”
Beyond Pulmonary Vein Isolation in Nonparoxysmal Atrial Fibrillation
Briceno, D. F., Patel, K., Romero, J. E., Alviz, I., Tarantino, N. M., Rocca, D. G. D., Natale, V. N., Zhang, X.-D., & Biase, L. D. (2020) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2020.01.002 · Cited by 16
Utility of High-frequency Jet Ventilation in Atrial Fibrillation Ablation
Babapoor-Farrokhran, S., Alzubi, J. M., Port, Z., Khraisha, O., & Mainigi, S. K. (2021) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2021.120708 · Cited by 15
Three-dimensional catheter tip force sensing using multi-core fiber Bragg gratings
Al-Ahmad, O., Ourak, M., Vlekken, J., Lindner, E., & Poorten, E. V. (2023) · Frontiers in Robotics and AI · doi:10.3389/frobt.2023.1154494 · Cited by 15
“A common treatment of AFib is through ablation and scarring of cardiac tissue with the aim of impeding occurrences of irregular contraction waves (Calkins et al., 2009).”
BackgroundCheng, X., Li, X., He, Y., Liu, X., Wang, G., Cheng, L. T., & Hu, J. (2014) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-014-9945-4 · Cited by 14
Hof, I. E., Vonken, E.-J. P. A., Velthuis, B. K., Wittkampf, F. H. M., van der Heijden, J. F., Neven, K. G. E. J., Kassenberg, W., Meine, M., Cramer, M. J., Hauer, R. N. W., et al. (2013) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-013-9860-0 · Cited by 15
Perino, A. C., Hoang, D. D., Holmes, T. H., Santangeli, P., Heidenreich, P. A., Perez, M. V., Wang, P. J., & Turakhia, M. P. (2014) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.114.000912 · Cited by 16
“Covariates were (1) success rate, R, for maintaining sinus rhythm; (2) number of patients, N, included in the study; (3) impact factor, I, of the journal in which the study was published; (4) whether the first or last author was a pre-eminent expert, E; (5) presence of RCT study design, D; (6) whether study reported m…”
BackgroundManagement of Atrial Fibrillation in Elderly Adults
Desai, Y. B., El‐Chami, M. F., León, A. R., & Merchant, F. M. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14483 · Cited by 16
“5.(57) The higher prevalence of persistent AF and the underrepresentation in AF ablation trials pose challenges when assessing the efficacy of ablation in elderly adults.”
BackgroundLohrmann, G. M., Kaplan, R. M., Ziegler, P., Monteiro, J., & PASSMAN, R. S. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14781 · Cited by 15
Müller, P., Maier, J., Dietrich, J. W., Barth, S., Griese, D. P., Schiedat, F., Szöllösi, A., Halbfaß, P., Nentwich, K., Roos, M., et al. (2015) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-015-0020-6 · Cited by 15
Antiarrhythmic therapy following ablation of atrial fibrillation
Stabile, G., Iuliano, A., Agresta, A., Rocca, V. L., D’Ascia, S. L., & Simone, A. D. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.811982 · Cited by 15
Kaneko, M., Nagata, Y., Nakamura, T., Mitsui, K., Nitta, G., Nagase, M., Okata, S., Watanabe, K., Miyazaki, R., Nagamine, S., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.03.004 · Cited by 14
Mukai, Y., Nakanishi, K., Daimon, M., Iwama, K., Yoshida, Y., Hirose, K., Yamamoto, Y., Seki, H., Nakao, T., Oshima, T., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030325 · Cited by 14
Early management of atrial fibrillation: from imaging to drugs to ablation
Shah, A. J., Liu, X., Jadidi, A., & Haı̈ssaguerre, M. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.49 · Cited by 14
“Although amiodarone is the most effective of the currently recommended drugs for maintenance of sinus rhythm, it is often discontinued owing to adverse effects”
BackgroundQin, D., Leef, G. C., Alam, M. B., Rattan, R., Munir, M. B., Patel, D. R., Khattak, F. H., Vaghasia, N., ADELSTEIN, E. C., Jain, S. K., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001793 · Cited by 15
“Also, these trials focused primarily on maintenance of sinus rhythm while providing inadequate information on other important outcome measures, such as AF-related hospitalizations or procedures.(11,13) Our study examined the use of AAD in a real-world clinical setting, without any patient selection or exclusion, focus…”
BackgroundLifestyle Therapy for the Management of Atrial Fibrillation
Abdul-Aziz, A. A., Altawil, M., Lyon, A., MacEachern, M., Richardson, C. R., Rubenfire, M., Pelosi, F., & Jackson, E. A. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.01.023 · Cited by 14
Wen, S., Indrabhinduwat, M., Brady, P. A., Pislaru, C., Miller, F. A., Ammash, N. M., Nkomo, V. T., Padang, R., Pislaru, S. V., & Lin, G. (2021) · Cardiovascular Ultrasound · doi:10.1186/s12947-021-00250-5 · Cited by 14
Han, J., Li, G., Zhang, D., Wang, X., & Guo, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.907817 · Cited by 14
Martı́n, A., Lozano, I. F., Puig, B. C.-V., Tercedor, L., del Arco, C., Ynsaurriaga, F. A., Méndez, C. S., & Girbau, L. M. (2012) · Emergencias · Cited by 14
Steinberg, B. A., Broderick, S. H., Lópes, R. D., Shaw, L. K., Thomas, K. L., DeWald, T. A., Daubert, J. P., Peterson, E. D., Granger, C. B., & Piccini, J. P. (2014) · EP Europace · doi:10.1093/europace/euu077 · Cited by 14
de Loma-Osorio, A. F., Izquierdo, M., Martínez-Brotons, Á. M., Sánchez‐Gómez, J. M., Mascarell, B., Ruiz-Ros, V., Cuenca-Romero, I., García–Civera, R., Chorro, F. J., & Ruiz‐Granell, R. (2013) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-013-9797-3 · Cited by 14
Percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation
Swaans, M. J., Post, M. C., Rensing, B. J. W. M., & Boersma, L. V. A. (2012) · Netherlands Heart Journal · doi:10.1007/s12471-011-0236-8 · Cited by 14
Moran, D., Regibus, V. D., de Asmundis, C., Takarada, K., Mugnai, G., Ströker, E., Aryana, A., Iacopino, S., Ruggiero, D., Coutiño-Moreno, H. E., et al. (2016) · EP Europace · doi:10.1093/europace/euw395 · Cited by 14
Mesquita, J., Cavaco, D., Ferreira, A. J. M., Costa, F. M., Carmo, P., Morgado, F., Mendes, M., & Adragão, P. (2018) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-018-0340-4 · Cited by 14
“methodological differences between reports [9, 10].”
BackgroundLeef, G. C., Perino, A. C., Cluckey, A., Yunus, F. N., Askari, M., Heidenreich, P. A., Narayan, S. M., Wang, P. J., & Turakhia, M. P. (2018) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13439 · Cited by 14
Safety and Effectiveness of a Next-Generation Contact Force Catheter
Lo, M. Y., Sanders, P., Sommer, P., Kalman, J. M., Siddiqui, U., Sundaram, S., Piorkowski, C., Olson, N., Madej, S., & Gibson, D. N. (2021) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2021.01.019 · Cited by 14
Maccioni, S., Sharma, R., Lee, D. D., Haltner, A., Khanna, R., & Vijgen, J. M. (2024) · Advances in Therapy · doi:10.1007/s12325-023-02765-x · Cited by 12
The Hot and the Cold: Radiofrequency Versus Cryoballoon Ablation for Atrial Fibrillation
Ang, R., Domenichini, G., Finlay, M., SCHILLING, R. J., & Hunter, R. J. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0631-7 · Cited by 13
From European to National guidelines on heart disease
Grip, L., Lindahl, B., Levin, L., Kärvinge, C., Eklund, K., & Wallentin, L. C. (2010) · Scandinavian Cardiovascular Journal · doi:10.3109/14017431.2010.536566 · Cited by 13
Chung, I., Khan, Y. M. A., Warrens, H., Seshasai, R. K., Sohal, M., & Banerjee, D. (2022) · Cardiorenal Medicine · doi:10.1159/000525388 · Cited by 13
Sohara, H., Satake, S., Takeda, H., Yamaguchi, Y., Toyama, H., Kumagai, K., Kuwahara, T., Takahashi, A., & Ohe, T. (2012) · Journal of Arrhythmia · doi:10.1016/j.joa.2012.07.005 · Cited by 13
Anselmino, M., Matta, M., Toso, E., Ferraris, F., Castagno, D., Scaglione, M., Cesarani, F., Faletti, R., & Gaïta, F. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.796 · Cited by 13
Baimbetov, A. K., Bizhanov, K. A., Аbzaliyev, K., Bairamov, B. A., & Yakupova, I. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14083 · Cited by 13
RetractedZhao, H., Li, X., Yu, P., Liu, M., Ma, J., Wang, J., Zhu, W., & Liu, X. (2023) · Nutrition & Metabolism · doi:10.1186/s12986-023-00724-5 · Cited by 12
“Catheter ablation of AF is a recognized treatment method to prevent recurrence of AF, especially for drugrefractory symptomatic AF [6].”
BackgroundInsights into the Role of Galectin-3 as a Diagnostic and Prognostic Biomarker of Atrial Fibrillation
Kia, Y. M., Cannavò, A., Bahiraie, P., Alilou, S., Saeedian, B., Babajani, N., Ghondaghsaz, E., Khalaji, A., & Behnoush, A. H. (2023) · Disease Markers · doi:10.1155/2023/2097012 · Cited by 13
Böhm, A., Tóthová, Ľ., Urban, L., Slezak, P. P., Bachárová, L., Musil, P., & Hatala, R. (2016) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2016.03.007 · Cited by 12
“[9,10].”
Hohnloser, S. H., Camm, A. J., Cappato, R., Diener, H., Heidbüchel, H., Lanz, H., Mont, L., Morillo, C. A., Smolnik, R., Yin, O. Q. P., et al. (2018) · Clinical Cardiology · doi:10.1002/clc.22918 · Cited by 12
Millenaar, D., Becker, N., Pavlicek, V., Wintrich, J., Böhm, M., Mahfoud, F., & Ukena, C. (2021) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14216 · Cited by 11
“total number of patients, (2) number of patients with inducible AF, and (3) number ofAF recurrences in this group, (4) number of patientswithout inducible AF, and (5) number of AF recurrences in this group, (6) type of AF: paroxysmal versus persistent versus both, (7) use of isoproterenol: yes versu no, (8) stimulatio…”
BackgroundDeshpande, R., Al‐Khadra, Y., SINGANALLUR, P. M., Botchway, A., & Labedi, M. R. (2022) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-022-01365-z · Cited by 13
Surface ECG f Wave Analysis of Dofetilide Drug Effect in the Atrium
Raygor, V., Ng, J., & Goldberger, J. J. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12645 · Cited by 12
Viles-González, J. F., Fuster, V., Halperin, J. L., Calkins, H. G., & Reddy, V. Y. (2011) · Clinical Cardiology · doi:10.1002/clc.20857 · Cited by 12
New treatment options for atrial fibrillation: towards patient tailored therapy
Smit, M. D., & Gelder, I. C. V. (2011) · Heart · doi:10.1136/heartjnl-2011-300276 · Cited by 12
Radiofrequency Ablation for Treatment of Atrial Fibrillation
Safaei, N., Montazerghaem, H., Azarfarin, R., Alizadehasl, A., & Alikhah, H. (2011) · Europe PMC (PubMed Central) · doi:10.5681/bi.2011.023 · Cited by 12
“Studies of RFCA for treatment of AF report higher efficacy rates than do studies of AAD therapy and a lower rate of complications (Calkins et al. 2009).”
BackgroundPharmacological therapy following catheter ablation of atrial fibrillation
Rordorf, R., Savastano, S., Gandolfi, E., Vicentini, A., Petracci, B., & Landolina, M. (2011) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32834d5880 · Cited by 12
Cardiac Lesion Mapping In Vivo Using Intracardiac Myocardial Elastography
Bunting, E., Papadacci, C., Wan, E. Y., Sayseng, V., Grondin, J., & Konofagou, E. E. (2017) · IEEE Transactions on Ultrasonics Ferroelectrics and Frequency Control · doi:10.1109/tuffc.2017.2768301 · Cited by 12
“2768301 been reported in the range of 53%–57% for a single procedure and 71%–80% after multiple procedures [1], [2].”
Convergent ablation for persistent atrial fibrillation: Single center experience
Gulkarov, I. M., Wong, B. C., Kowalski, M., Worku, B., Afzal, A., Ivanov, A. V., Ramasubbu, K., & Reddy, B. (2019) · Journal of Cardiac Surgery · doi:10.1111/jocs.14204 · Cited by 12
Franzetti, J., Volpe, S., Catto, V., Conte, E., Piccolo, C., Pepa, M., Piperno, G., Camarda, A. M., Cattani, F., Andreini, D., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.849201 · Cited by 12
Osmancik, P. P., Neužil, P., Hozmanová, J., Petrů, J., Heřman, D., Královec, Š., Hozman, M., Tichý, M., Waldauf, P., Karel, T., et al. (2026) · Circulation · doi:10.1161/circulationaha.126.079484 · Cited by 11
Rodríguez‐Entem, F., Expósito, V., Rodríguez‐Mañero, M., González‐Enríquez, S., Fernández‐López, X. A., García‐Seara, J., Martínez‐Sande, J. L., & Olalla, J. J. (2015) · Journal of Arrhythmia · doi:10.1016/j.joa.2015.09.011 · Cited by 11
“The acute success rate was similar or even superior to that obtained using standard RF ablation with the point-by-point approach [7].”
ResultTotally Thoracoscopic Surgical Ablation or Catheter Ablation of Atrial Fibrillation
Edgerton, J. R., Philpot, L. M., Falley, B., & Barnes, S. A. (2012) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2012.05.001 · Cited by 11
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.07.001 · Cited by 11
Jobst, S., Leppla, L., & Köberich, S. (2020) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00624-y · Cited by 14
Angelini, F., Bocchino, P. P., Peyracchia, M., Saglietto, A., Magnano, M., Patanè, N., D’Ascenzo, F., Giustetto, C., Anselmino, M., Gaïta, F., et al. (2021) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2021.2005307 · Cited by 11
Lone Atrial Fibrillation: Where Are We Now?
Potpara, T., & Lip, G. Y. H. (2011) · Hospital Practice · doi:10.3810/hp.2011.10.919 · Cited by 11
Role of three-dimensional imaging integration in atrial fibrillation ablation
Ponti, R. D. (2010) · World Journal of Cardiology · doi:10.4330/wjc.v2.i8.215 · Cited by 11
Osca, J., Andrés, A., Cano, Ó., Alonso, P., Tello, M. J. S., Olagüe, J., Martínez‐Dolz, L., & Salvador, A. (2015) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2015.08.022 · Cited by 11
“9 [1-23] 4 5 7 6”
Wójcik, M., Erkapic, D., Berkowitsch, A., Zaltsberg, S., Greiß, H., Schmitt, J., Pajitnev, D., Lehinant, S., Rixe, J., Hamm, C. W., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0275 · Cited by 11
Gal, P., Buist, T. J., Smit, J. J. J., Adıyaman, A., Misier, A. R. R., Delnoy, P. P. H. M., & Elvan, A. (2016) · Netherlands Heart Journal · doi:10.1007/s12471-016-0907-6 · Cited by 11
“Although PVI has proven to be an effective treatment for AF, some patients develop recurrences [3, 15].”
BackgroundD’Angelo, R. N., Khanna, R., Yeh, R. W., Goldstein, L. J., Kalsekar, I. D., Marcello, S. R., Tung, P., & ZIMETBAUM, P. J. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01446-9 · Cited by 12
Alrumayh, A., & Alobaida, M. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1905873 · Cited by 11
Wu, H., Xu, J., Chen, S., Zhou, G., Qi, B., Wei, Y. Q., Hu, E., Tang, D., Chen, G., Li, H., et al. (2017) · Scientific Reports · doi:10.1038/srep44003 · Cited by 11
Scar Homogenization in Atrial Fibrillation Ablation: Evolution and Practice
Saini, A., Huizar, J. F., Tan, A. Y., Koneru, J. N., Ellenbogen, K. A., & Kaszala, K. (2017) · Journal of Atrial Fibrillation · doi:10.4022/jafib.1645 · Cited by 11
Apixaban is Dear to Me, but Dearer Still is Warfarin
Biase, L. D., & Natale, A. (2015) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12570 · Cited by 11
Exercise-based cardiac rehabilitation for adults with atrial fibrillation
Risom, S. S., Zwisler, A., Palm, P., Sibilitz, K. L., Lindschou, J., Taylor, R. S., Gluud, C. N., Svendsen, J. H., & Berg, S. K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011197 · Cited by 11
Thoracoscopic Surgical Ablation of Lone Atrial Fibrillation: Long-term Outcomes at 7 Years
Muneretto, C., Baudo, M., Rosati, F., Petruccelli, R. D., Curnis, A., Bacco, L. D., & Benussi, S. (2023) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2023.04.033 · Cited by 10
Impact of frailty in patients with non‐valvular atrial fibrillation undergoing catheter ablation
Soejima, K., Nogami, A., Kumagai, K., Uno, K., Kurita, T., Morishima, I., Miura, F., Kato, R., Kimura, T., Takita, A., et al. (2024) · Journal of Arrhythmia · doi:10.1002/joa3.13038 · Cited by 10
Long-term clinical outcome of patients who failed catheter ablation of atrial fibrillation
Bottoni, N., Bertaglia, E., Donateo, P., Quartieri, F., Iori, M., Maggi, R., Zoppo, F., BRANDOLINO, G., & Brignole, M. (2014) · EP Europace · doi:10.1093/europace/euu229 · Cited by 10
Cervigón, R., Castells, F., Gomez-Pulido, J. M., Pérez‐Villacastín, J., & Moreno, J. (2018) · Entropy · doi:10.3390/e20010057 · Cited by 10
“Pulmonary vein catheter ablation is a widely used procedure that isolates the pulmonary veins from the rest of the heart and prevents any pulses from these veins from getting into the heart, restoring normal rhythm in patients with AF [41].”
BackgroundBarrio-López, M. T., Castellanos, E., Ortiz, M., Arceluz, M. R., Lázaro, C., Salas, J., Madero, S., & Almendral, J. M. (2018) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-018-0371-x · Cited by 10
“After the first ablation procedure, up to 30% of the patients present AF recurrences [2], mainly due to PV reconnections [3].”
BackgroundZhang, H., Zhu, L., Nathan, V., Kuang, J., Kim, J., Gao, J. A., & Olgin, J. E. (2021) · Proceedings of the ACM on Interactive Mobile Wearable and Ubiquitous Technologies · doi:10.1145/3463503 · Cited by 14
Kim, R., Simon, S. T., Powers, B., Sandhu, A., Sánchez, J. M., Borne, R. T., Tumolo, A. Z., Zipse, M. M., West, J. J., Aleong, R. G., et al. (2021) · JMIR Medical Informatics · doi:10.2196/29225 · Cited by 10
“As such, the treatment of AF beyond identification of individuals needing anticoagulation is generally directed toward one of two strategies: (1) a rate-control strategy, focused solely on reducing the rate of ventricular excitation without attempting to restore sinus rhythm, or (2) a rhythm-control strategy, in which…”
MethodZuercher, R., Herling, A., Schmidt, M. T., Bachmann, M., Winnik, S. H., Duru, F., & Eriksson, U. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092546 · Cited by 10
Metadata
- Authors
- Calkins, H., Reynolds, M. R., Spector, P., Sondhi, M., Xu, Y., Martin, A., Williams, C. J., & Sledge, I.
- Affiliations
- University of Vermont (US)
- Venue
- Circulation Arrhythmia and Electrophysiology
- Published
- 2009-08
- Volume
- 2
- Issue
- 4
- Pages
- 349-361
- ISSN
- 1941-3084 (ISSN-L)
- 1941-3149
- OpenAlex
- W2020741490
- Cited by
- 847
- References
- 128
- Citations by year
- 2026: 19 · 2025: 29 · 2024: 42 · 2023: 33 · 2022: 38 · 2021: 48 · 2020: 35 · 2019: 37 · 2018: 43 · 2017: 54 · 2016: 62 · 2015: 63 · 2014: 72 · 2013: 69 · 2012: 74
- FWCI
- 43.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Arrhythmia and Electrophysiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- atrial fibrillation, radiofrequency catheter ablation, antiarrhythmic drugs, amiodarone, dofetilide, sotalol, flecainide, propafenone, treatment efficacy, procedural complications, ablation success rate
- MeSH terms
- Anti-Arrhythmia Agents, Atrial Fibrillation, Humans, Catheter Ablation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review